248 related articles for article (PubMed ID: 25872335)
1. Combination therapy of liposomal paclitaxel and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Li Y; Wang X; Li J; Ding W
Eur J Gynaecol Oncol; 2015; 36(1):54-8. PubMed ID: 25872335
[TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience.
Selvaggi L; Loizzi V; DI Gilio AR; Nardelli C; Cantatore C; Cormio G
Int J Gynecol Cancer; 2006; 16(2):631-7. PubMed ID: 16681738
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix.
Sit AS; Kelley JL; Gallion HH; Kunschner AJ; Edwards RP
Cancer Invest; 2004; 22(3):368-73. PubMed ID: 15493357
[TBL] [Abstract][Full Text] [Related]
6. A modified shortened administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer.
Ren Y; Li Y; Liu J
Int J Gynecol Cancer; 2011 May; 21(4):685-9. PubMed ID: 21543932
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.
Kumar JV; Doval DC; Rao R; Rawal S
Int J Gynecol Cancer; 2009 Apr; 19(3):417-22. PubMed ID: 19407570
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.
Park DC; Kim JH; Lew YO; Kim DH; Namkoong SE
Gynecol Oncol; 2004 Jan; 92(1):59-63. PubMed ID: 14751139
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Takekuma M; Hirashima Y; Ito K; Tsubamoto H; Tabata T; Arakawa A; Itani Y; Furukawa N; Murakoshi H; Takeuchi S
Gynecol Oncol; 2012 Sep; 126(3):341-5. PubMed ID: 22609108
[TBL] [Abstract][Full Text] [Related]
10. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
11. [Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
CHEN XD; SHI HY; LÜ WG; QIN JL
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):173-6. PubMed ID: 21575388
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
Mori T; Hosokawa K; Kinoshita Y; Watanabe A; Honjo H
Int J Gynecol Cancer; 2008; 18(1):85-9. PubMed ID: 17587314
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.
Dueñas-Gonzalez A; Lopez-Graniel C; Gonzalez A; Reyes M; Mota A; Muñoz D; Solorza G; Hinojosa LM; Guadarrama R; Florentino R; Mohar A; Meléndez J; Maldonado V; Chanona J; Robles E; De la Garza J
Ann Oncol; 2001 Apr; 12(4):541-7. PubMed ID: 11398890
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy for advanced cervical cancer].
Kodama J; Ikuhashi H; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Park DC; Suh MJ; Yeo SG
Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
